Sophie Opdyke BPharm, MBA

Sophie Opdyke is the Commercial Development Lead for Global Established Products (GEP) at Pfizer Inc. Drawing from over 15 years of experience in business development, new product development and global marketing, Sophie has an excellent understanding of the global healthcare environment, customers’ needs, key market trends, and business development for pharmaceuticals. She is responsible for the development and execution of Pfizer’s biosimilars commercial strategy to ensure Pfizer’s biosimilars portfolio is poised to meet patient demand for greater access to safe and effective treatments. Sophie has a proven ability to lead high performing cross-functional global teams and excels at creating and implementing strategy across Pfizer’s various sectors of business. Sophie speaks frequently on her expertise in commercial development, specifically on topics that include measuring the size of the biosimilars market, considering degrees of competitiveness, incorporating pricing differential assessment, and performing lifecycle management for targeted biologics. She attended the School of Pharmacy in Paris and holds an MBA from Columbia University.